Lynx1 Capital Management LP - 30 Jun 2025 SCHEDULE 13G/A Report for TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)

Filing Manager: Lynx1 Capital Management LP
Reporting Manager: Lynx1 Capital Management LP
Security: TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share
Symbol: TCRX
Shares outstanding: 52,382,313 shares
Disclosed Ownership: 7,857,347 shares
Ownership: 15%
Form type: SCHEDULE 13G/A
Filing time: 14 Aug 2025, 07:06:26 UTC
Date of event: 30 Jun 2025
Previous filing: 14 Feb 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Lynx1 Capital Management LP	15%	7,857,347	0	7,857,347	/s/ Weston Nichols	By: Lynx1 Capital Management GP LLC, General Partner, By: Weston Nichols, Sole Member
Weston Nichols	15%	7,857,347	0	7,857,347	/s/ Weston Nichols	Weston Nichols, Individually